Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Sarcoma × Nivolumab × Clear all

Phase

Phase 2 14 Phase 1/2 6 Phase 1 4 Phase EARLY_PHASE1 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 21 Melanoma 20 Carcinoma, Renal Cell 12 Stomach Neoplasms 8 Lung Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 5 Brain Neoplasms 5 Mesothelioma 4 Kidney Neoplasms 4 Carcinoma, Hepatocellular 4 Adenocarcinoma Of Esophagus 4 Urinary Bladder Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Head and Neck Neoplasms 3 Various Advanced Cancer 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Mesothelioma, Malignant 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma 2 Anus Neoplasms 2 Adenocarcinoma 2 von Hippel-Lindau Disease 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Thoracic Neoplasms 1

Interventions

Doxorubicin 22 Ifosfamide 19 Radiotherapy 14 Vincristine 9 Etoposide 9 Filgrastim 8 Cyclophosphamide 8 Trabectedin 7 Dactinomycin 7 pazopanib 4 Cisplatin 4 Topotecan 3 Radiation 3 Irinotecan 3 Granulocyte Colony-Stimulating Factor 3 Chemotherapy, Adjuvant 3 sargramostim 2 etoposide phosphate 2 eribulin 2 Observation 2 Methotrexate 2 Mesna 2 Imatinib Mesylate 2 Gemcitabine 2 Docetaxel 2 Dexrazoxane 2 Dacarbazine 2 trofosfamide 1 trioctyl phosphine oxide 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04741438 2023-08-30

RAR-Immune

Centre Leon Berard

Phase 3 Unknown

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡